Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Tech Reporter Virgin Islands.
Press releases published on October 22, 2025
Ipsen delivers strong sales in the first nine months of 2025 and further upgrades its full-year guidance
Year-to-date total sales growth of 12.1% at CER1, or 9.6% as reported, driven by all three therapeutic areas and including strong performance from Iqirvo®, Bylvay® and Somatuline® Further upgrade of full-year 2025 financial guidance based on slower than …
Ipsen enregistre une forte dynamique commerciale au cours des neuf premiers mois de l'année 2025 et revoit à la hausse ses prévisions pour l'exercice en cours
Croissance du chiffre d’affaires du Groupe de 12,1 % à taux de change constant1 au cours des neuf premiers mois de l’année 2025, ou 9,6 % en données publiées, portée par les trois aires thérapeutiques et incluant les solides performances d’Iqirvo®, Bylvay® …
Press Release: Sanofi’s efdoralprin alfa met all primary and key secondary endpoints in alpha-1 antitrypsin deficiency emphysema phase 2 study
Sanofi’s efdoralprin alfa met all primary and key secondary endpoints in alpha-1 antitrypsin deficiency emphysema phase 2 study Efdoralprin alfa demonstrated superiority in a head-to-head study versus a standard of care plasma-derived therapy Results …
Communiqué de presse : L’efdoralprine alfa de Sanofi a atteint tous les critères d’évaluation principaux et secondaires clés dans l’étude de phase II sur l’emphysème par déficit en alpha-1-antitrypsine
L’efdoralprine alfa de Sanofi a atteint tous les critères d’évaluation principaux et secondaires clés dans l’étude de phase II sur l’emphysème par déficit en alpha-1-antitrypsine L’efdoralprine alfa a démontré sa supériorité dans une une étude comparative …
Ipsen to acquire ImCheck Therapeutics, expanding its leadership in oncology, strengthening its pipeline
Acquisition focused on lead clinical-stage program ICT01 in acute myeloid leukemia, where data from the ongoing Phase I/II EVICTION trial showed high treatment response ICT01 has the potential to be a new standard of care in combination in first line unfit …
Ipsen annonce son intention d’acquérir ImCheck Therapeutics et étend son leadership en oncologie avec un portefeuille enrichi de produits en R&D
Acquisition axée sur le programme clinique phare ICT01 dans le domaine de la leucémie myéloïde aiguë, dont les données issues de l'essai EVICTION de phase I/II en cours ont montré une réponse thérapeutique élevée. ICT01 pourrait devenir une nouvelle norme …
ENA Respiratory Attracts US$22.4m (AU$34m) to Fund Phase II Development of INNA-051 Nasal Spray Designed to Protect Against Symptomatic Viral Respiratory Infections
MELBOURNE, Australia, Oct. 22, 2025 (GLOBE NEWSWIRE) -- ENA Respiratory, a clinical-stage pharmaceutical company developing antiviral host defense enhancers to minimize the impact of symptomatic viral respiratory infections, announces today that it has …
Adlai Nortye to Present Short Talk on AN4035 Preclinical Results at AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
SINGAPORE and NORTH BRUNSWICK, N.J. and HANGZHOU, China, Oct. 22, 2025 (GLOBE NEWSWIRE) -- Adlai Nortye Ltd. (NASDAQ: ANL) (the “Company” or “Adlai Nortye”), a clinical-stage biotechnology company focused on the development of innovative cancer therapies, …
RAPT Therapeutics Announces Pricing of Public Offering of Common Stock
SOUTH SAN FRANCISCO, Calif., Oct. 21, 2025 (GLOBE NEWSWIRE) -- RAPT Therapeutics, Inc. (Nasdaq: RAPT) (“RAPT”), a clinical-stage immunology-based biopharmaceutical company focused on discovering, developing and commercializing novel therapies for patients …
Safer Roads, Smarter Fleets: Geotab & Vitality Launch Data-Driven Behavioural Science Joint Venture
SYDNEY, Oct. 21, 2025 (GLOBE NEWSWIRE) -- Geotab Inc. and its affiliates (“Geotab”), the global leader in connected vehicle and asset solutions, and Vitality, have formed a joint venture to improve driver safety and well-being, reduce risk and support …
WePlay x Care Bears Halloween Carnival Party Officially Kicks Off!
BRASÍLIA, Brazil, Oct. 21, 2025 (GLOBE NEWSWIRE) -- As Halloween night falls, WePlay teams up with the globally beloved IP Care Bears™ to launch a heartwarming and magical “Halloween Carnival Party”! More than just a festive celebration, this collaboration …
WePlay x Care Bears Carnaval de Halloween oficialmente começou! Use a magia fofinha dos ursinhos para iluminar sua noite de diversão
BRASÍLIA, Brasil, Oct. 21, 2025 (GLOBE NEWSWIRE) -- Com a chegada da noite de Halloween, a WePlay se uniu ao clássico IP global "Care Bears™ (Ursinhos Carinhosos)" para criar uma “Halloween Carnival Party” repleta de surpresas e aconchego! Este não é …
Pixelligent Launches PixMicro™ Product Line to Advance XR, Next-Generation Displays, and Optical Sensors
BALTIMORE, Oct. 21, 2025 (GLOBE NEWSWIRE) -- Pixelligent Technologies LLC (Pixelligent), the leading manufacturer of high refractive index (RI) nanocomposites for next-gen electronics, today introduced PixMicro™, the next leap in Micro Optics materials. …